Jane Huang

CIK 1683913 · President, CMO · last filed 2026-06-16

Jane Huang is a President, CMO who has filed 73 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for TARA, was dated Jun 16, 2026. Across all open-market trades the lifetime net is −$39.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $317.2K across reported positions. 53 SEC filings were submitted jointly with BeiGene, Ltd.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$317.2K

Companies

Total Filings

Lifetime Open-Market Net

-$39.82M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

C/O MOURANT OZANNES CORPORATE SERVICES
94 SOLARIS AVENUE
CAMANA BAY

Related Filers

BeiGene, Ltd. — 53 joint filings, latest 2021-12-16

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
TARA	Director	—	$2.69	—	$0	6	2026-06-16
PRLD	President, CMO	86,917	$3.65	$317.2K	-$81.3K	15	2025-10-07
BeOne Medicines Ltd. (BGNE) Delisted	CMO, Hematology	0	$184.71	$0	-$39.74M	52	2021-12-16

Recent Filings

73 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-06-16	TARA	Grant (A)	—	$0	EDGAR
2025-10-07	PRLD	Mixed	+6,020	-$4.9K	EDGAR
2025-07-08	PRLD	Mixed	+6,020	-$2.7K	EDGAR
2025-06-13	TARA	Grant (A)	—	$0	EDGAR
2025-04-07	PRLD	Mixed	+6,020	-$2.3K	EDGAR
2025-02-05	PRLD	Grant (A)	—	$0	EDGAR
2025-01-07	PRLD	Mixed	+5,516	-$5.4K	EDGAR
2024-10-07	PRLD	Mixed	+6,026	-$6.7K	EDGAR
2024-07-08	PRLD	Mixed	+6,028	-$12.0K	EDGAR
2024-06-10	TARA	Grant (A)	—	$0	EDGAR

Showing 1–10 of 73

Page 1 of 8 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.